Ozempic Hair Loss: Why It Happens and What Helps

Medically reviewed by Jane Yoo, MD, board-certified dermatologist | Updated November 13th, 2026

If you have started noticing more hair in the shower drain or on your brush since beginning Ozempic, Wegovy, Mounjaro or Zepbound, you are not imagining it. Hair shedding is a recognized, well-documented experience with GLP-1 medications. For most people it is temporary, and it is rarely a reason to stop a medication that is working for your health.

Is hair loss a real side effect of GLP-1 medications?

Yes, the signal is consistent across several kinds of evidence. In the tirzepatide obesity trials, hair loss was reported in roughly 4 to 5 percent of participants compared with about 1 percent on placebo. A systematic review of 24 studies found that semaglutide and tirzepatide had the highest incidence of hair loss among GLP-1 medications. A large 2026 cohort study of electronic health records found a higher risk of a new non-scarring hair loss diagnosis with semaglutide and tirzepatide than with metformin.

Two honest caveats. First, most of this evidence is observational, so it shows association rather than proving cause. Second, the absolute risk of a new hair loss diagnosis in these datasets was low, so the majority of people taking these medications do not develop clinically significant hair loss.

Why it happens: telogen effluvium

The leading explanation is not that the drug poisons hair follicles. It is that rapid weight loss is a physiologic stressor, and the body responds by shifting a larger share of hair follicles into the resting (telogen) phase. A few months later those hairs shed. Dermatologists call this telogen effluvium.

Several clues support this explanation. Shedding typically begins about two to four months after the stressor, which fits the biology of the hair cycle. The medications most associated with hair loss, semaglutide and tirzepatide, are also the ones that produce the greatest weight loss. And the lower-efficacy GLP-1 medications such as liraglutide and dulaglutide did not show the same signal in the large cohort study. Reduced calorie, protein and micronutrient intake may add to the effect.

What GLP-1 hair loss looks like

  • Diffuse shedding across the whole scalp rather than one patch.
  • A ponytail that feels thinner, or a part that looks slightly wider.
  • Hair coming out in larger amounts when washing or brushing.
  • A normal-looking scalp with no redness, scale or pain.

One important nuance: telogen effluvium can also unmask pattern hair loss that was already developing. The large cohort study grouped several diagnoses together and could not separate them, so if your thinning is concentrated at the part or crown, or does not settle, it is worth having it evaluated.

Who may be more likely to notice it

  • People losing weight quickly or losing a large amount of weight.
  • Women, in whom hair loss was reported more often in pooled weight-loss trials.
  • Anyone with pre-existing thinning, a prior episode of telogen effluvium, or low iron.
  • People eating much less protein or overall food than usual.

What helps

  • Do not stop or change your medication on your own. Talk with the clinician who prescribed it, who can weigh the hair effect against the benefit to your health.
  • Protect your nutrition. Work with your prescriber or a dietitian to keep protein and micronutrient intake adequate while eating less.
  • Get the basics checked. Ferritin, thyroid function and vitamin D are reasonable starting points when shedding is significant. See our guide to nutrition and labs on a GLP-1.
  • Consider topical minoxidil if you also have thinning. It is available over the counter and is commonly used while hair recovers.
  • Be gentle with your hair. Avoid tight styles, heavy heat and harsh chemical processing while the hair is fragile.
  • Be patient. Recovery takes months. See the regrowth timeline.

When to see a dermatologist

Make an appointment if shedding lasts beyond about six months, if you see patches of loss, if your scalp is itchy, tender or scaly, or if your part is steadily widening. A clinical exam can tell telogen effluvium from pattern hair loss and rule out other causes.

Hair changes can be one piece of the broader skin and body changes that come with significant weight loss. If you are also concerned about facial volume or loose skin, see our guides to Ozempic face and loose skin after weight loss.

—

Frequently asked questions

Is hair loss more common with tirzepatide or semaglutide?

Both are associated with hair loss. In some analyses tirzepatide shows a somewhat higher risk, which fits its greater average weight loss, but direct comparisons are limited and the numbers vary by study.

Should I stop my GLP-1 medication if my hair is falling out?

Not on your own. Hair shedding from weight loss is usually temporary. Discuss it with your prescriber, who can review your dose, your nutrition and whether anything else is contributing.

Will taking biotin stop Ozempic hair shedding?

There is no good evidence that biotin prevents telogen effluvium in people who are not deficient. High-dose biotin can also interfere with some lab tests, so tell your clinician if you take it.

—

Concerned about hair thinning or shedding? Dr. Jane Yoo is a board-certified dermatologist in Midtown Manhattan. A proper diagnosis comes first, because the right treatment depends on the type of hair loss. Book a consultation.

This article is for educational purposes and does not replace an in-person medical evaluation.

author avatar
Dr. Jane Yoo Board-Certified Dermatologist and Mohs Surgeon
Jane Yoo, MD, MPP, is a Korean American board-certified dermatologist and fellowship-trained Mohs surgeon based in Midtown Manhattan. She is a Clinical Assistant Professor at the Icahn School of Medicine at Mount Sinai and the founder of Jane Yoo MD, PLLC and the Clinical Research Center of New York. Dr. Yoo holds an undergraduate degree from MIT and a Masters of Public Policy from Harvard's Kennedy School of Government. She completed her Mohs micrographic surgery fellowship at Yale. Her clinical and research focus spans aesthetic clinical trials including injectables and laser technology, skincare formulation and sunscreen science, K-Beauty and skin of color, ultrasound guided filler dissolution, artificial intelligence and beauty tech. Dr. Yoo's research is indexed under ORCID 0000-0002-7112-8963.